Inventor

TUNG ROGER D

US77 patents

⚠️ This page may combine multiple inventors who share the name “TUNG ROGER D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

22 patents

US6372778B1Apr 16, 2002

Sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA142 citations99

US5585397ADec 17, 1996

Sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA246 citations99

US5516797AMay 14, 1996

Immunosuppressive compounds

VERTEX PHARMA121 citations99

US5330993AJul 19, 1994

Immunosuppressive compounds

VERTEX PHARMA143 citations99

US6617309B2Sep 9, 2003

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

VERTEX PHARMA103 citations98

US6265380B1Jul 24, 2001

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

VERTEX PHARMA200 citations98

US5723490AMar 3, 1998

THF-containing sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA108 citations98

US7388017B2Jun 17, 2008

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

VERTEX PHARMA77 citations97

US5192773AMar 9, 1993

Immunosuppressive compounds

VERTEX PHARMA163 citations97

US6436989B1Aug 20, 2002

Prodrugs of aspartyl protease inhibitors

VERTEX PHARMA62 citations96

US5783701AJul 21, 1998

Sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA49 citations96

US5622970AApr 22, 1997

Immunosuppressive compounds

VERTEX PHARMA61 citations95

US5693847ADec 2, 1997

Heteroatom functionalized α-methyl ketones

VERTEX PHARMA33 citations93

US6608067B1Aug 19, 2003

Inhibitors of serine proteases, particularly HCV NS3 protease

VERTEX PHARMA52 citations92

US5977137ANov 2, 1999

Sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA26 citations92

US5912269AJun 15, 1999

Butyrate prodrugs derived from lactic acid

VERTEX PHARMA34 citations92

US5856353AJan 5, 1999

Sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA33 citations92

US5691372ANov 25, 1997

Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA18 citations92

US7713983B2May 11, 2010

Quinazolines useful as modulators of ion channels

VERTEX PHARMA18 citations90

US5990155ANov 23, 1999

Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease

VERTEX PHARMA10 citations74

US5883123AMar 16, 1999

Butyrate prodrugs derived from lactic acid

VERTEX PHARMA13 citations73

US5880152AMar 9, 1999

Butyrate prodrugs derived from lactic acid

VERTEX PHARMA7 citations70

CONCERT PHARMACEUTICALS INC

18 patents

US9540367B2Jan 10, 2017

Deuterated baricitinib

CONCERT PHARMACEUTICALS INC32 citations94

US9309182B2Apr 12, 2016

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC29 citations94

US10040748B2Aug 7, 2018

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC6 citations84

US9815763B2Nov 14, 2017

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC7 citations84

US9035050B2May 19, 2015

Substituted xanthine derivatives

CONCERT PHARMACEUTICALS INC7 citations84

US11161798B2Nov 2, 2021

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC2 citations73

US10532971B2Jan 14, 2020

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC3 citations73

US10343968B2Jul 9, 2019

Deuterated idebenone

CONCERT PHARMACEUTICALS INC2 citations73

US10017445B2Jul 10, 2018

Deuterated idebenone

CONCERT PHARMACEUTICALS INC3 citations73

US9931343B2Apr 3, 2018

Deuterated baricitinib

CONCERT PHARMACEUTICALS INC4 citations73

US9868976B2Jan 16, 2018

Morphinan compounds

CONCERT PHARMACEUTICALS INC3 citations73

US10668036B2Jun 2, 2020

Deuterated analogs of D-serine and uses thereof

CONCERT PHARMACEUTICALS INC4 citations72

US9328113B2May 3, 2016

Substituted xanthine derivatives

CONCERT PHARMACEUTICALS INC3 citations72

US11939285B2Mar 26, 2024

4-hydroxybutyric acid analogs

CONCERT PHARMACEUTICALS INC0 citations63

US9918987B2Mar 20, 2018

Substituted xanthine derivatives

CONCERT PHARMACEUTICALS INC1 citations63

US9492457B2Nov 15, 2016

Substituted xanthine derivatives

CONCERT PHARMACEUTICALS INC2 citations63

US9493463B2Nov 15, 2016

Substituted xanthine derivatives

CONCERT PHARMACEUTICALS INC2 citations63

US9422295B2Aug 23, 2016

Deuterated ibrutinib

CONCERT PHARMACEUTICALS INC2 citations63

TUNG ROGER D

6 patents

US8461197B2Jun 11, 2013

4-hydroxybutyric acid analogs

TUNG ROGER D78 citations98

US8987442B2Mar 24, 2015

Deuterium-substituted xanthine derivatives and methods of use

TUNG ROGER D53 citations97

US8759394B2Jun 24, 2014

4-hydroxybutyric acid analogs

TUNG ROGER D72 citations97

US8263601B2Sep 11, 2012

Deuterium substituted xanthine derivatives

TUNG ROGER D28 citations92

US9051261B2Jun 9, 2015

4-hydroxybutyric acid analogs

TUNG ROGER D10 citations84

US8952016B2Feb 10, 2015

Substituted xanthine derivatives

TUNG ROGER D5 citations73

(unassigned)

1 patent

US5665774ASep 9, 1997

Immunosuppressive compounds

MASSE CRAIG E

1 patent

US8575221B2Nov 5, 2013

Derivatives of dimethylcurcumin

MASSE CRAIG E26 citations92

MERCK & CO INC

1 patent

US5225528AJul 6, 1993

Cyclic hexapeptide oxytocin antagonists

MERCK & CO INC14 citations74

VERTEX PHARMACEUTICALS EUROPE LTD

1 patent

US10759721B2Sep 1, 2020

Deuterated CFTR potentiators

VERTEX PHARMACEUTICALS EUROPE LTD5 citations72

Showing the top 50 of 77 patents by PatentIndex Score.